Entresto Tablets 50mg, manufactured by Novartis Pharma, contain Sacubitril Valsartan Sodium Hydrate, a combination product that acts as an angiotensin receptor-neprilysin inhibitor (ARNI). With YJ code 2190041F1027 and a standard of 50mg per tablet, it is used to reduce the risk of cardiovascular death and hospitalization for heart failure in adults and symptomatic heart failure in children aged one year and older.
Entresto Tablets 50mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →